Publications Database

Anagnostou E. et al. (2012)

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial.

Molecular Autism

3(16),

Read Abstract (New Window) Read Full (New Window)

Bartz J. A. , Hollander E. (2008)

Oxytocin and experimental therapeutics in autism spectrum disorders.

Progress in Brain Research

170 pp. 451-462

Read Abstract (New Window)

Gotham K. et al. (2008)

A replication of the Autism Diagnostic Observation Schedule (ADOS) revised algorithms.

Journal of the American Academy of Child and Adolescent Psychiatry

47(6), pp. 642-651

Read Abstract (New Window)

Hirota T. et al. (2014)

Antiepileptic medications in autism spectrum disorder: A systematic review and meta-analysis.

Journal of Autism and Developmental Disorders

44(4), pp. 948-957.

Read Abstract (New Window)

Hollander E. et al. (2006)

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

Journal of Child and Adolescent Psychopharmacology

16 pp. 541-548

Read Abstract (New Window)

Hollander E. et al. (2012)

A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders.

American Journal of Psychiatry

169(3), pp. 292-299.

Read Abstract (New Window)

Hollander E. et al. (2001)

An open trial of divalproex sodium in autism spectrum disorders.

Journal of Clinical Psychiatry

July, 62(7), pp. 530-534

Read Abstract (New Window)

Hollander E. et al. (2006)

Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder.

International Journal of Neuropsycholpharmacology

9(2), pp. 209-213

Read Abstract (New Window)

Hollander E. , Lundberg G. (2008)

New developments in autism spectrum disorders.

Medscape Journal of Medicine

10(6), p. 152

Read Full (New Window)

Hollander E. et al. (2007)

Oxytocin increases retention of social cognition in autism.

Biological Psychiatry

61(4), pp. 498-503

Read Abstract (New Window) Read Full (New Window)

Hollander E. et al. (2003)

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

Neuropsychopharmacology

28 pp. 193-198

Read Abstract (New Window) Read Full (New Window)

Hollander E. , Phillips A. , Yeh. C. (2003)

Targeted treatments for symptom domains in child and adolescent autism.

Lancet

362(9385), pp. 732-734

Read Abstract (New Window)

Hollander E. (1998)

Treatment of obsessive-compulsive spectrum disorders with SSRIs.

British Journal of Psychiatry Supplement

35 pp. 7-12

Read Abstract (New Window)

King B. H. et al. (2013)

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: A multisite randomized clinical trial.

JAMA Pediatrics

November, 167(11),

Read Abstract (New Window)

King B. H. et al. (2009)

Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism.

Archives of General Psychiatry

66(6), pp. 583-590

Read Abstract (New Window)

Kolevzon A. , Mathewson K. , Hollander E. (2006)

Selective serotonin reuptake inhibitors in autism: a review of efficacy and tolerability.

Journal of Clinical Psychiatry

67(3), pp. 407-414

Read Abstract (New Window)

Parikh M. , Kolevzon A. , Hollander E. (2008)

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

Journal of Child and Adolescent Psychopharmacology

April, 18(2), pp. 157-178

Read Abstract (New Window)

Soorya L. , Hollander E. , Kiarashi J. (2008)

Psychopharmacologic interventions for repetitive behaviors in autism spectrum disorders.

Child and Adolescent Psychiatric Clinics of North America

17(4), pp. 753-771

Read Abstract (New Window)

Umbricht D. et al. (2016)

A single dose, randomized, controlled proof-of-mechanism study of a novel vasopressin 1a receptor antagonist (RG7713) in high-functioning adults with autism spectrum disorder.

Neuropsychopharmacology

Read Abstract (New Window)

Wasserman S. et al. (2006)

Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.

International Clinical Psychopharmacology

21(6), pp. 363-367

Read Abstract (New Window)